KINASERA® Streptokinase 1,500,000 IU | Libya
KINASERA supports advanced emergency care protocols, helping healthcare providers in Libya
Streptokinase 1,500,000 IU Injection | BAYADERCARE Libya
Rapid thrombolytic intervention is essential in emergency and critical care settings, particularly in life-threatening conditions where immediate restoration of blood flow is required. Fibrinolytic therapy plays a key role in improving survival outcomes in acute cardiovascular events.
|
KINASERA® 1,500,000 IU (Streptokinase Vial Injection) is a high-strength thrombolytic therapy used for rapid clot dissolution in acute and life-threatening cardiovascular conditions. It activates plasminogen to plasmin, breaking down fibrin clots and restoring blood circulation.
|
| Applications / Uses: |
| Acute Myocardial Infarction (Heart Attack) |
| Pulmonary Embolism (PE) |
| Deep Vein Thrombosis (DVT) |
| Emergency thrombolytic therapy |
| Critical care cardiovascular management |
FAQ
Is KINASERA 1,500,000 IU available in Libya?
Yes, it is available through BAYADERCARE across Libya.
What is it used for?
| Emergency thrombolytic therapy in acute cardiovascular conditions. |
Where is it used?
| Emergency departments, ICU, and cardiac care units. |